← All organizations

TrippBio, Inc.

For profit

Also known as: TrippBio, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Dec 31, 2023

Timeline

No events for the selected filters.

Drugs by trial phase (2 distinct, 3 trials)

Phase 2 (1 own, 0 via acquisition)

probenecid

Phase 1 (1 own, 0 via acquisition)

procaine benzylpenicillin

Recent trials (6)

NCT06025318Lead sponsorPhase 1Dec 31, 2023
NCT06025318Study directorPhase 1Dec 31, 2023
NCT06025344Lead sponsorPhase 1Dec 31, 2023
NCT06025344Study directorPhase 1Dec 31, 2023
NCT05442983Lead sponsorPhase 2Jul 12, 2022
NCT05442983Study directorPhase 2Jul 12, 2022

Details

Last known activity: Dec 31, 2023